NCT02946996 2026-03-05
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Phase 2 Terminated
Clinical Trials
31 trialsNCT03109847 2025-12-11
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Thomas Jefferson University
Phase 2 Terminated
NCT06884683 2025-03-19
NivoMet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Terminated
NCT03047837 2025-01-27
ASAMET
Ente Ospedaliero Ospedali Galliera
Phase 2 Terminated
NCT02523898 2024-04-25
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Semnan University of Medical Sciences
Phase 2 Terminated
NCT01996696 2024-01-30
PREMIUM
AHS Cancer Control Alberta
Phase 2 Terminated
NCT02640534 2023-06-27
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Swiss Cancer Institute
Phase 2 Terminated
NCT02420652 2023-02-08
PRIMA
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT02531308 2022-09-28
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT02945813 2022-04-14
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Swiss Cancer Institute
Phase 2 Terminated
NCT01929811 2022-04-06
NeoMET
Shanghai Jiao Tong University School of Medicine
Phase 2 Terminated
NCT04170959 2021-01-15
RADFORMIN
University Hospital, Antwerp
Phase 2 Terminated
NCT01627067 2020-06-19
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02115464 2020-04-22
ALMERA
Ontario Clinical Oncology Group (OCOG)
Phase 2 Terminated
NCT01717482 2020-03-10
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Mayo Clinic
Phase 2 Terminated
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02190838 2019-11-25
Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Terminated
NCT02472353 2019-10-16
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Phase 2 Terminated
NCT01523639 2018-12-19
G-LUCAS
Austrian Breast & Colorectal Cancer Study Group
Phase 2 Terminated
NCT01578551 2018-12-19
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01926769 2018-05-15
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer
Gachon University Gil Medical Center
Phase 2 Terminated
NCT02019979 2018-05-04
METRO
Beth Israel Medical Center
Phase 2 Terminated
NCT02473094 2017-11-28
NEOMETRE
University of Campinas, Brazil
Phase 2 Terminated
NCT02815397 2017-11-17
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215032 2017-05-15
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Terminated
NCT01997775 2016-09-30
Metformin in Stage IV Lung Adenocarcinoma
National Cheng-Kung University Hospital
Phase 2 Terminated
NCT01632020 2016-07-11
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
University of Arkansas
Phase 2 Terminated
NCT01167738 2015-04-24
PACT-17
IRCCS San Raffaele
Phase 2 Terminated
NCT01477060 2014-02-20
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Fondazione Michelangelo
Phase 2 Terminated
NCT00881725 2012-06-19
ANIMATE
University Health Network, Toronto
Phase 2 Terminated